Perflexane

CHEMBL1200607 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
338.0 g/mol
LogP
5.1
Phase
4

A perfluorocarbon liquid investigated as a blood substitute and oxygen carrier, and also studied as an ultrasound contrast agent. Its ability to dissolve large amounts of oxygen makes it a candidate for treating ischemia and enhancing tumor oxygenation during radiation therapy.

Moleküler Ağırlık

338,0400 g/mol

LogP

5,10

TPSA

0,00 Ų

Lipinski RO5

Başarısız

Terapötik Alanlar

Etki Mekanizması

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

FC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F

InChI

InChI=1S/C6F14/c7-1(8,3(11,12)5(15,16)17)2(9,10)4(13,14)6(18,19)20

Molecular Formula

C6F14

HBD / HBA

- / 14

Döndürülebilir Bağlar

3

Ağır Atomlar

20

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A perfluorocarbon liquid investigated as a blood substitute and oxygen carrier, and also studied as an ultrasound contrast agent. Its ability to dissolve large amounts of oxygen makes it a candidate for treating ischemia and enhancing tumor oxygenation during radiation therapy.

Enhances the contrast of specific tissues or structures during medical imaging procedures by altering the local signal intensity or X-ray absorption characteristics.

Yes, Perflexane is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200607. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 9639. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.